These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38751415)

  • 1. A qualitative investigation of the Montgomery-Åsberg depression rating scale: discrepancies in rater perceptions and data trends in remote assessments of rapid-acting antidepressants in treatment resistant depression.
    Capodilupo G; Blattner R; Must A; Navarro SG; Opler M
    Front Psychiatry; 2024; 15():1289630. PubMed ID: 38751415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Individual Items of the Patient Health Questionnaire (PHQ-9) and Montgomery-Asberg Depression Rating Scale (MADRS) in Adults with Treatment-Resistant Depression Treated with Esketamine Nasal Spray Combined with a New Oral Antidepressant.
    Floden L; Hudgens S; Jamieson C; Popova V; Drevets WC; Cooper K; Singh J
    CNS Drugs; 2022 Jun; 36(6):649-658. PubMed ID: 35441931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Montgomery-Åsberg Depression Rating Scale factors in treatment-resistant depression at onset of treatment: Derivation, replication, and change over time during treatment with esketamine.
    Borentain S; Gogate J; Williamson D; Carmody T; Trivedi M; Jamieson C; Cabrera P; Popova V; Wajs E; DiBernardo A; Daly EJ
    Int J Methods Psychiatr Res; 2022 Dec; 31(4):e1927. PubMed ID: 35749277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inter-rater reliability among psychiatrists when assessing depression according to the Montgomery-Åsberg Depression Rating Scale.
    Geijer J; Baigi A; Aiff H
    Nord J Psychiatry; 2021 Nov; 75(8):607-613. PubMed ID: 34156321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. THE DEPRESSION INVENTORY DEVELOPMENT SCALE: Assessment of Psychometric Properties Using Classical and Modern Measurement Theory in a CAN-BIND Trial.
    Vaccarino AL; Kalali AH; Blier P; Gilbert Evans S; Engelhardt N; Foster JA; Frey BN; Greist JH; Kobak KA; Lam RW; MacQueen G; Milev R; Müller DJ; Parikh SV; Placenza FM; Rizvi SJ; Rotzinger S; Sheehan DV; Sills T; Soares CN; Turecki G; Uher R; Williams JBW; Kennedy SH; Evans KR
    Innov Clin Neurosci; 2020 Jul; 17(7-9):30-40. PubMed ID: 33520402
    [No Abstract]   [Full Text] [Related]  

  • 6. The inter-rater reliability of the Japanese version of the Montgomery-Asberg depression rating scale (MADRS) using a structured interview guide for MADRS (SIGMA).
    Takahashi N; Tomita K; Higuchi T; Inada T
    Hum Psychopharmacol; 2004 Apr; 19(3):187-92. PubMed ID: 15079853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meaningful Change in Depression Symptoms Assessed with the Patient Health Questionnaire (PHQ-9) and Montgomery-Åsberg Depression Rating Scale (MADRS) Among Patients with Treatment Resistant Depression in Two, Randomized, Double-blind, Active-controlled Trials of Esketamine Nasal Spray Combined With a New Oral Antidepressant.
    Hudgens S; Floden L; Blackowicz M; Jamieson C; Popova V; Fedgchin M; Drevets WC; Cooper K; Lane R; Singh J
    J Affect Disord; 2021 Feb; 281():767-775. PubMed ID: 33261932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence to Support Montgomery-Asberg Depression Rating Scale Administration Every 24 Hours to Assess Rapid Onset of Treatment Response.
    Johnson KM; Devine JM; Ho KF; Howard KA; Saretsky TL; Jamieson CA
    J Clin Psychiatry; 2016 Dec; 77(12):1681-1686. PubMed ID: 28086004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant.
    Ballard ED; Luckenbaugh DA; Richards EM; Walls TL; Brutsché NE; Ameli R; Niciu MJ; Vande Voort JL; Zarate CA
    J Psychiatr Res; 2015 Sep; 68():68-73. PubMed ID: 26228403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rater Training for a Multi-Site, International Clinical Trial: What Mood Symptoms may be most Difficult to Rate?
    Sajatovic M; Gaur R; Tatsuoka C; De Santi S; Lee N; Laredo J; Tripathi S
    Psychopharmacol Bull; 2011 Sep; 44(3):5-14. PubMed ID: 27738359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between serotonin transporter polymorphisms (5-HTTLPR) and the MADRS Dysphoria, Retardation, and Vegetative Subscale scores in the treatment of depression.
    Takahashi H; Higuchi H; Sato K; Kamata M; Yoshida K; Nishimura K
    Neuropsychiatr Dis Treat; 2017; 13():1463-1469. PubMed ID: 28652746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administering the MADRS by telephone or face-to-face: a validity study.
    Hermens ML; Adèr HJ; van Hout HP; Terluin B; van Dyck R; de Haan M
    Ann Gen Psychiatry; 2006 Mar; 5():3. PubMed ID: 16553958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cross-cultural comparison study of depression assessments conducted in Japan.
    Targum SD; Nakagawa A; Sato Y
    Ann Gen Psychiatry; 2013 Apr; 12(1):9. PubMed ID: 23551964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A symptom-based approach in predicting ECT outcome in depressed patients employing MADRS single items.
    Carstens L; Hartling C; Stippl A; Domke AK; Herrera-Mendelez AL; Aust S; Gärtner M; Bajbouj M; Grimm S
    Eur Arch Psychiatry Clin Neurosci; 2021 Oct; 271(7):1275-1284. PubMed ID: 34269881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability and validity of the telephone-based version of the Montgomery-Asberg depression rating scale for assessing depression in individuals with primary brain tumour.
    Harris G; Jones S; Pinkham MB; Lion KM; Ownsworth T
    Disabil Rehabil; 2024 Mar; 46(6):1158-1166. PubMed ID: 37021336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and reliability of a structured interview guide for the Montgomery Asberg Depression Rating Scale (SIGMA).
    Williams JB; Kobak KA
    Br J Psychiatry; 2008 Jan; 192(1):52-8. PubMed ID: 18174510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The self-reported Montgomery-Asberg Depression Rating Scale is a useful evaluative tool in Major Depressive Disorder.
    Fantino B; Moore N
    BMC Psychiatry; 2009 May; 9():26. PubMed ID: 19473506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnitude of change with antidepressants and placebo in antidepressant clinical trials using structured, taped and appraised rater interviews (SIGMA-RAPS) compared to trials using traditional semi-structured interviews.
    Khan A; Faucett J; Brown WA
    Psychopharmacology (Berl); 2014 Nov; 231(22):4301-7. PubMed ID: 24770630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The course of depression in late life as measured by the Montgomery and Asberg Depression Rating Scale in an observational study of hospitalized patients.
    Borza T; Engedal K; Bergh S; Benth JŠ; Selbæk G
    BMC Psychiatry; 2015 Aug; 15():191. PubMed ID: 26242794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary on Cochrane review: "Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder".
    Borentain S; Desai P; Fu DJ; Nancy Chen L; Lane R; Mathews M; Canuso CM
    J Psychopharmacol; 2023 Aug; 37(8):836-844. PubMed ID: 36218274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.